Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial. - Henderson, Michael A; Burmeister, Bryan H; Ainslie, Jill; Fisher, Richard; Di Iulio, Juliana; Smithers, B Mark; Hong, Angela; Shannon, Kerwin; Scolyer, Richard A; Carruthers, Scott; Coventry, Brendon J; Babington, Scott; et al. (Lancet Oncology, 2015)